Alexandre Caron

Alexandre Caron is an Assistant Professor at Laval University in the Faculty of Pharmacy, where he teaches and conducts research in metabolic physiology and pharmacology. He is actively involved in advancing the understanding of brain-organ communication in metabolic diseases.

Education:

• Bachelor’s in Medical Biology, Université du Québec à Trois-Rivières (2007–2010)
• Master’s in Physiology-Endocrinology, Laval University (2010–2011)
• Doctorate in Physiology-Endocrinology, Laval University (2012–2015)
• Postdoctoral Fellowship in Neurometabolism, University of Texas Southwestern Medical Center (2015–2020)

Dr. Caron's research focuses on the mechanisms by which the brain regulates energy metabolism, particularly in the context of obesity, diabetes, and insulin resistance. His work explores leptin signaling, G protein-coupled receptor pathways, and pharmacological strategies to treat metabolic disorders. He investigates how disruptions in brain-organ communication contribute to pathophysiological states and aims to develop effective drug combinations to improve glucose and lipid metabolism. His interdisciplinary approach bridges neuroscience, endocrinology, and pharmacology.

His recent publications (2018–2020) reflect a strong thematic focus on central metabolic control, adipose tissue regulation, and neuroendocrine signaling. Key areas include leptin receptor expression in neural and vascular tissues, melanocortin pathways, and hepatokine actions. These works appear in high-impact journals such as Cell Metabolism, Nature Reviews Neuroscience, and Molecular Metabolism, indicating significant contributions to the field of metabolic neuroscience.

Scientific Awards:

• Rolls-Simons Award, The Obesity Society (2019)
• Junior Investigator Award, Journal of Lipid Research (2019)
• Keystone Symposia Scholarship (2019)
• Pathway to Independence Award (K99/R00), NIDDK (2019–2020)
• Banting Postdoctoral Fellowship (2018–2020)

Dr. Caron has been supported by competitive grants including the Banting Fellowship and NIH K99/R00 award, reflecting strong recognition of his research potential. While no formal students are listed, his postdoctoral and independent research roles suggest active mentorship and collaboration. He teaches key pharmacy courses such as PHA-1022 (Nervous System), PHA-3027 (Competent Reporting), and research-focused projects, contributing to both undergraduate and graduate training.

His research is conducted within a neuroscience and metabolism laboratory environment, likely involving collaborations across institutions, particularly with the Elmquist and Laplante labs. His future work is expected to deepen understanding of brain-adipose-liver axes and develop novel pharmacotherapies for metabolic syndrome.